{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477395679
| IUPAC_name = dihydrogen [(±)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5−)]gadolinate(2−).
| image = Structure of Gadobenic acid.png
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|gadobenic-acid}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 113662-23-0
| ATC_prefix = V08
| ATC_suffix = CA08
| PubChem = 105124
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00743
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 94843
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 15G12L5X8K
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08018
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200571
<!--Chemical data-->
| C=22 | H=28 | Gd=1 | N=3 | O=11
| molecular_weight = 667.72 g/mol
| smiles = [H+].[H+].[Gd+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)C(C([O-])=O)COCc1ccccc1
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C22H31N3O11.Gd/c26-18(27)10-23(6-7-24(11-19(28)29)12-20(30)31)8-9-25(13-21(32)33)17(22(34)35)15-36-14-16-4-2-1-3-5-16;/h1-5,17H,6-15H2,(H,26,27)(H,28,29)(H,30,31)(H,32,33)(H,34,35);/q;+3/p-3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = MXZROTBGJUUXID-UHFFFAOYSA-K
}}

'''Gadobenic acid''' ([[International Nonproprietary Name|INN]], trade name '''MultiHance''') is a complex of [[gadolinium]] with the ligand BOPTA. In the form of the [[meglumine|methylglucamine]] salt '''meglumine gadobenate''' ([[International Nonproprietary Name|INNm]]) or '''gadobenate dimeglumine''' ([[United States Adopted Name|USAN]]), it is used as a [[gadolinium-based MRI contrast medium]].<ref name=Martindale>{{Cite book|editor=Sweetman, Sean C. |chapter=Contrast Media|title=[[Martindale: The Complete Drug Reference]] |edition=36th |year=2009 |pages=1478|publisher=Pharmaceutical Press |location=London|isbn=978-0-85369-840-1}}</ref>

BOPTA is a derivative of [[DTPA]] in which one terminal carboxyl group, –C(O)OH is replaced by -C–O–CH<sub>2</sub>C<sub>6</sub>H<sub>5</sub>. Thus gadobenic acid is closely related to [[gadopentetic acid]]. BOPTA itself was first synthesized in 1995.
<ref name =synth>{{cite journal
| last1        = Uggeri
| first1       = F.
| last2        = Aime, S., Anelli, P.L., Botta, M., Brocchetta, M., De Haën, C., Ermondi, G., Grandi, M., Paoli, P.
| year         = 1995
| title        = Novel contrast agents for magnetic resonance imaging. Synthesis and characterization of the ligand BOPTA and its Ln(III) complexes (Ln = Gd, La, Lu). X-ray structure of disodium (TPS-9-145337286-C-S)-[4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8, 11-triazatridecan-13-oato(5-)]gadolinate(2-) in a mixture with its enantiomer
| journal      = Inorg. Chem.
| volume       = 34 
| issue        = 3
| pages        = 633–642
| doi          =  10.1021/ic00107a017 
}}</ref>
In the "gadobenate" ion gadolinium ion is 9-coordinate with BOPTA acting as an 8-coordinating ligand. The ninth position is occupied by a water molecule, which exchanges rapidly with water molecules in the immediate vicinity of the strongly [[paramagnetic]] complex, providing a mechanism for [[Magnetic resonance imaging|MRI contrast enhancement]]. <sup>139</sup>La NMR studies on the diamagnetic La-BOPTA<sup>2−</sup> complex suggest that the Gd complex maintains in solution the same kind of coordination as found, by X-ray crystallography, in the solid state for Gd-BOPTA disodium salt.<ref name=synth/>

==See also==
* [[Gadopentetic acid]]
* [[Gadoxetic acid]]

==References==
{{reflist}}

{{Contrast media}}

[[Category:MRI contrast agents]]
[[Category:Gadolinium compounds]]


{{pharmacology-stub}}